Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
89,070
-
Share change
-
+88,627
-
Total reported value
-
$130,157
-
Price per share
-
$1.46
-
Number of holders
-
9
-
Value change
-
+$129,510
-
Number of buys
-
8
Institutional Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) as of Q4 2024
As of 31 Dec 2024,
Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,070 shares.
The largest 9 holders included
Virtu Financial LLC, CITADEL ADVISORS LLC, TWO SIGMA INVESTMENTS, LP, Tower Research Capital LLC (TRC), BlackRock, Inc., Carolina Wealth Advisors, LLC, BANK OF AMERICA CORP /DE/, UBS Group AG, and CITIGROUP INC.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.